SCHEMBL23451016

SCHEMBL23451016

CC(=O)NCc1ccc(-c2ccc(C[C@@H](C)NC(C)=O)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ACACB O00763 19/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25543753 0.90 ACACB (0.58) ACACB
SCHEMBL26161772 0.85 KMT2A (0.54) —
SCHEMBL12001230 0.84 ACACB (0.83) ACACB
SCHEMBL12001232 0.84 ACACB (0.75) ACACB
SCHEMBL12001223 0.84 ACACB (0.75) ACACB
SCHEMBL255701 0.84 ACACB (0.65) ACACB
SCHEMBL12001337 0.84 ACACB (0.80) ACACB
SCHEMBL12001233 0.83 ACACB (0.76) ACACB
SCHEMBL12001188 0.83 ACACB (0.76) ACACB
SCHEMBL12001067 0.83 ACACB (0.76) ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021108662-A1 COMPOUND COMPRISING A NUCLEIC ACID AND A HALF-LIFE EXTENSION MOTIF DTX PHARMA, INC. (US) 2021-06-03 — — WO disclosed
Send feedback